Trials / Terminated
TerminatedNCT03880565
Advanced Reperfusion Strategies for Refractory Cardiac Arrest
Advanced REperfusion STrategies for Refractory Cardiac Arrest (The ARREST Trial)
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- University of Minnesota · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a Phase II, single center (Under the Center for Resuscitation Medicine at the University of Minnesota Medical School), partially blinded, prospective, intention to treat, safety and efficacy clinical trial, randomizing adult patients (18-75 years old) with refractory ventricular fibrillation/pulseless ventricular tachycardia (VF/VT) out-of hospital cardiac arrest (OHCA) who are transferred by emergency medical services (EMS) with ongoing mechanical cardiopulmonary resuscitation (CPR) or who are resuscitated to receive one of the 2 local standards of care practiced in our community: 1) Early Extracorporeal Membrane Oxygenation (ECMO) Facilitated Resuscitation or 2) Standard Advanced Cardiac Life Support (ACLS) Resuscitation
Conditions
- Cardiac Arrest
- Extracorporeal Membrane Oxygenation Complication
- Ventricular Fibrillation
- Pulseless Ventricular Tachycardia
- Out-Of-Hospital Cardiac Arrest
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Early Extracorporeal Membrane Oxygenation (ECMO) Facilitated Resuscitation | Early use of ECMO |
| DEVICE | Standard Advanced Cardiac Life Support (ACLS) Resuscitation | Standard life support resuscitation |
Timeline
- Start date
- 2019-08-09
- Primary completion
- 2020-10-09
- Completion
- 2020-10-09
- First posted
- 2019-03-19
- Last updated
- 2022-03-10
- Results posted
- 2021-11-22
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03880565. Inclusion in this directory is not an endorsement.